NFGH
TRML

Nan Fung Group Holdings’s Tourmaline Bio TRML Stock Holding History

Nan Fung Group Holdings’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-227,090
Closed -$3.45M – 31
2025
Q1 		$3.45M Buy
227,090
+40,000
+21% +$641K 2.82% 16
2024
Q4 		$3.79M Buy
187,090
+40,290
+27% +$1.01M 3.25% 13
2024
Q3 		$3.77M Hold
146,800
– – 3.25% 13
2024
Q2 		$1.89M Buy
146,800
+125,813
+599% +$2.02M 2.01% 15
2024
Q1 		$481K Buy
+20,987
New +$740K 0.45% 31

Other funds holding TRML

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

Nan Fung Group Holdings's TRML Position: Q2 2025 in Review

Nan Fung Group Holdings sold out of Tourmaline Bio (TRML) in Q2 2025, closing a stake of 227,090 shares — an estimated $3.45M sold.

Nan Fung Group Holdings first reported a position in TRML in Q1 2024 and held it in 5 quarters. The position peaked at $3.79M in Q4 2024. 108 funds tracked by Wall St. Rank hold TRML as of Q2 2025.

  • Nan Fung Group Holdings reported no remaining Tourmaline Bio position as of Q2 2025 after selling out during the quarter.
  • Nan Fung Group Holdings sold 227,090 Tourmaline Bio shares in Q2 2025, an estimated $3.45M.
  • Nan Fung Group Holdings first reported a position in Tourmaline Bio in Q1 2024 and held it in 5 quarters.
  • Nan Fung Group Holdings's Tourmaline Bio position peaked at $3.79M in Q4 2024.
  • 108 funds tracked by Wall St. Rank held Tourmaline Bio as of Q2 2025.

Based on Nan Fung Group Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.